LARRY ALFORD: Open Payments
NPI 1386699627 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,215 in 166 payments from 30 companies in 2025. Trend: 2023 $4,042 · 2024 $3,679 · 2025 $3,215
Food & beverage: $3,215
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $449 |
| GlaxoSmithKline, LLC. | 16 | $406 |
| ABBVIE INC. | 26 | $342 |
| Novo Nordisk Inc | 16 | $298 |
| Lilly USA, LLC | 11 | $195 |
| PFIZER INC. | 9 | $176 |
| Amgen Inc. | 9 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $144 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $111 |
Products named: TRELEGY ELLIPTA, JARDIANCE, VRAYLAR, FARXIGA, Kerendia, UBRELVY, AIRSUPRA, Auvelity.
Industry payments across AL — which companies pay providers there.
